Re-run eP2P Should Olumiant® be the JAKi of choice in rheumatoid arthritis? A review of the evidence
Free
Log In
Overview
This Activity for
- Resident / Fellow
- Physician
What I will learn?
- To review the latest Olumiant real world evidence and demonstrate the
consistency of results between this and the clinical evidence.
- To discuss why Olumiant should be used earlier in the treatment pathway
and is the perfect molecule to implement a treat to target approach.
- To agree that Olumiant should be a good contender for JAKI of choice.
About Organizer
- Virtual Medical Academy
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
| Re-run eP2P Should Olumiant® be the JAKi of choice in rheumatoid arthritis? A review of the evidence Certificate | Certificate | Free |
VAT 15% Included